Lilly Announces Positive Type 2 Diabetes Data

mia.burns Data Presented at 49th EASD Annual Meeting Show Treatment with Lilly’s Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes Improvements ...

GW Pharmaceuticals Announces Agreement on Sativex Pricing in Germany

barbara.lempert London, UK; 23 September 2013: GW Pharmaceuticals plc (AIM: GWP, Nasdaq: GWPH, “GW”) announced today that agreement for a revised mutually-acceptable ...

IMRIS Announces Addition of Dr. Vipul Patel to SYMBIS Advisory Board

barbara.lempert World’s most experienced robotic surgeon to consult on neurosurgical robot MINNEAPOLIS, Sept. 19, 2013 /CNW/ – Global intraoperative imaging company ...

AMAG Pharmaceuticals Announces Appointment of Barbara Deptula to Board of Directors

barbara.lempert LEXINGTON, Mass., Sept. 9, 2013 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Barbara Deptula, former executive vice president ...

iCo Therapeutics Announces Second Quarter 2013 Financial Results

barbara.lempert VANCOUVER, Aug. 26, 2013 /CNW/ – iCo Therapeutics (TSX-V: ICO), today reported financial results for the quarter ended June 30, 2013. Amounts, unless specified ...

Theravance Announces Reintroduction of VibativI

barbara.lempert Theravance Announces Reintroduction of VIBATIV(R) (telavancin) to the U.S. Market SOUTH SAN FRANCISCO, CA — (Marketwired) — 08/14/13 — Theravance, ...

Chimerix Announces Top Line Data From CMX001 Phase 2 Adenovirus Study

barbara.lempert Chimerix Announces Top Line Data From CMX001 Phase 2 Adenovirus Study and Late-Breaker Presentation at ICAAC   —  Encouraging results from the first proof-of-concept ...

Chelsea Therapeutics Announces Submission of Additional Information for Northera NDA

barbara.lempert Chelsea Therapeutics Announces Submission of Additional Information for NORTHERA(TM) (Droxidopa) NDA CHARLOTTE, N.C., Aug. 14, 2013 (GLOBE NEWSWIRE) — Chelsea ...

CTI Clinical Trial and Consulting Services Announces Hires

barbara.lempert CTI Clinical Trial and Consulting Services Announces that Thomas Winrod, RN has joined as Associate Director, Clinical Trials and Paula Ulsh, RN, BSN has joined as ...

Certara Announces Acquisition of Great Lakes Drug Development

barbara.lempert Certara Announces Acquisition of Great Lakes Drug Development, Inc. Acquisition will further increase the depth of Certara’s early drug development analysis, modeling ...

KannaLife Sciences Announces Creation of South Park Pharmaceuticals

barbara.lempert WEST HILLS, N.Y., Aug. 13, 2013 (GLOBE NEWSWIRE) — KannaLife Sciences, Inc. (“KannaLife”) and Biotech Inc. (“Biotech”), 50/50 joint venture ...

CollabRx Announces Oncology-Specific Mobile App

barbara.lempert CollabRx Announces Oncology-Specific Mobile App With Leading Site for Healthcare Professionals, MedPage Today SAN FRANCISCO, Aug. 13, 2013 (GLOBE NEWSWIRE) — ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS